This cohort study examines the association of a recall-based nirsevimab immunization strategy with the incidence of clinically diagnosed all-cause bronchiolitis during the 2024-2025 respiratory syncytial virus season in Italy.
Nirsevimab and a Community Recall-Based Immunization Strategy for Child Bronchiolitis Prevention
Brigadoi, Giulia;Barbieri, Elisa;Dona, Daniele;Giaquinto, Carlo;Baraldi, Eugenio;
2026
Abstract
This cohort study examines the association of a recall-based nirsevimab immunization strategy with the incidence of clinically diagnosed all-cause bronchiolitis during the 2024-2025 respiratory syncytial virus season in Italy.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
